How to Help Your Patients Save Money on Somatropin: A Provider's Guide to Savings Programs

Cost is one of the most significant barriers to somatropin therapy. At retail, growth hormone can exceed $1,000–$3,000 per month depending on dose and brand. Even with insurance, specialty tier copays and high deductibles create serious financial hardship for many families. The good news: a robust ecosystem of manufacturer programs, independent foundations, and pharmacy strategies can dramatically reduce what patients pay — but most of these require prescriber involvement to activate.

This guide provides a comprehensive overview of somatropin cost-reduction strategies for providers in 2026.

Understanding the Cost Landscape for Somatropin

Key cost factors for somatropin:

Brand variation: Omnitrope is typically the lowest-cost option. Norditropin and Genotropin carry higher retail prices. Serostim (for HIV wasting) is among the most expensive and is typically covered by most Medicare plans.

Insurance tier: Somatropin is typically a specialty Tier 4 or 5, with 20%–33% coinsurance — meaning a patient paying 20% coinsurance on a $2,000 monthly supply pays $400 per month before reaching their out-of-pocket maximum.

Medicare gap: Most Medicare Part D plans do not cover Genotropin. Adult GHD patients on Medicare face particular challenges.

Step 1: Prescribe the Formulary-Preferred Brand

Before prescribing, check the patient's formulary. Different plans place different somatropin brands on preferred tiers. Prescribing the non-preferred brand when a preferred one is available results in higher cost to the patient and often requires step therapy through the preferred brand first.

Many plans that require Omnitrope as the preferred step therapy brand will approve Norditropin or Genotropin after a trial of Omnitrope if the patient fails to respond or the PA documentation supports medical necessity for the non-preferred brand.

Step 2: Enroll Patients in Manufacturer Co-Pay Programs

For commercially insured patients, manufacturer co-pay assistance cards are the most powerful immediate cost-reduction tool. These programs can bring out-of-pocket costs to as low as $0 per fill:

Norditropin (NovoCare Co-Pay Savings): Commercially insured patients with Norditropin coverage may pay as little as $0, with an annual savings cap of $1,500. Valid for 48 months from enrollment; cap resets January 1 annually. Call 1-888-668-6444 or enroll via norditropin.com.

Sogroya (NovoCare Co-Pay Savings): Commercially insured patients with Sogroya coverage may pay as little as $0, with a significantly higher annual cap of $5,000. Enrollment through NovoCare.

Omnitrope (Sandoz Co-Pay Savings Program): Insured patients with Omnitrope coverage may pay as little as $0; cash-paying patients can save up to $417 per 30-day supply. Register at omnitrope.com/co-pay-savings-program or call 1-866-954-5512.

Genotropin (Pfizer): Co-pay assistance available through the specialty pharmacy or Pfizer's patient hub. Contact through prescribing system or specialty pharmacy liaison.

Step 3: Enroll Uninsured/Low-Income Patients in Patient Assistance Programs

For patients without insurance or who cannot afford their copay even with assistance, Patient Assistance Programs (PAPs) provide somatropin at no cost to eligible patients:

Novo Nordisk PAP (Norditropin/Sogroya): Available for patients with Medicare or no insurance with household income at or below 400% of the Federal Poverty Level (FPL). The prescriber must complete an enrollment form. Dispensed through Neovance Specialty Pharmacy (NPI: 1780811125). Contact NovoCare at 1-888-668-6444.

Sandoz/Novartis PAP (Omnitrope): Available for uninsured patients meeting income criteria. Prescriber enrollment required. Contact 1-866-954-5512.

Pfizer PAP (Genotropin): Available for uninsured or low-income patients. Apply through pparx.org or Pfizer's dedicated patient hub.

38,004+ patients found their medications in stock

38K+

Find Somatropin In Stock Today →

Step 4: Use Interim/Bridge Programs During PA Delays

Prior authorization delays can leave patients without medication for weeks. Novo Nordisk's NovoCare Interim Program provides a limited free supply of Norditropin or Sogroya to commercially insured patients while insurance issues are being resolved. This is particularly useful during shortage-related brand transitions when a new PA is pending. Eligibility is reviewed quarterly. Contact NovoCare to enroll patients in the Interim Program.

Step 5: Independent Foundations for Additional Support

For patients who do not qualify for manufacturer PAPs (e.g., those with commercial insurance who still face high costs), refer them to:

Good Days (mygooddays.org): Copay assistance for insured patients with qualifying diagnoses; call 1-877-968-7233

NeedyMeds (needymeds.org): Comprehensive PAP database; also lists disease-specific assistance programs

Magic Foundation: Nonprofit focused specifically on growth disorders; provides financial assistance and navigation support for GH-related conditions

Skip the calls, skip the stress.

Find Somatropin In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Help Patients Find Their Somatropin With medfinder

Even with savings programs in place, patients often can't find somatropin in stock. medfinder for providers allows providers to refer patients to a pharmacy-search service that calls pharmacies on the patient's behalf to locate in-stock somatropin. Combining financial assistance enrollment with medfinder's pharmacy search gives patients the highest chance of getting their medication affordably and quickly.

Also read: how to help your patients find somatropin in stock and somatropin shortage: what providers need to know in 2026.